UBE2G2
Ubiquitin-conjugating enzyme E2 G2
Also known as: UB2G2_HUMAN, UBC7
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P60604
- Gene
- UBE2G2
- Ensembl
- ENSG00000184787
- Chromosome
- 21
- Canonical length
- 165 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
OverviewNCBI Gene
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. The encoded protein shares 100% sequence identity with the mouse counterpart. This gene is ubiquitously expressed, with high expression seen in adult muscle. Three alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jan 2011]
Canonical amino-acid sequenceUniProt
165 residues, UniProt reviewed canonical sequence.
>P60604|UBE2G2
1 MAGTALKRLM AEYKQLTLNP PEGIVAGPMN EENFFEWEAL IMGPEDTCFE FGVFPAILSF
61 PLDYPLSPPK MRFTCEMFHP NIYPDGRVCI SILHAPGDDP MGYESSAERW SPVQSVEKIL
121 LSVVSMLAEP NDESGANVDA SKMWRDDREQ FYKIAKQIVQ KSLGLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against UBE2G2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 65 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 65 nTPM
- tongue: 48 nTPM
- heart muscle: 37 nTPM
- liver: 31 nTPM
- pancreas: 30 nTPM
- blood vessel: 29 nTPM
Single-cell type
- late spermatids: 308 nCPM
- myonuclei: 186 nCPM
- erythrocyte progenitors: 134 nCPM
- bergmann glia: 128 nCPM
- thymic myoid cells: 126 nCPM
- alveolar cells type 1: 125 nCPM
Immune cell
- plasmacytoid DC: 25 nTPM
- MAIT T-cell: 23 nTPM
- memory CD8 T-cell: 21 nTPM
- naive CD8 T-cell: 21 nTPM
- T-reg: 21 nTPM
- NK-cell: 21 nTPM
Brain region
- white matter: 20 nTPM
- basal ganglia: 18 nTPM
- pons: 17 nTPM
- thalamus: 17 nTPM
- midbrain: 17 nTPM
- spinal cord: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.86
- gnomAD pLI
- 0.1
- gnomAD missense Z
- 1.8
- DepMap mean gene effect
- -0.28
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to interferon-beta
- ERAD pathway
- negative regulation of retrograde protein transport, ER to cytosol
- protein K48-linked ubiquitination
- protein polyubiquitination
- ubiquitin-dependent protein catabolic process
Molecular functions
- ATP binding
- identical protein binding
- ubiquitin conjugating enzyme activity
- ubiquitin-protein transferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of UBE2G2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads UBE2G2 as an antibody target. Whether an autoantibody or antibody against UBE2G2 could matter depends on whether native UBE2G2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
UBE2G2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label UBE2G2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...